Expertise in
4
conditions

Peter R. Reynolds

St. Peter's Hospital, Ashford & St. Peter's Hospitals NHS Foundation Trust, Surrey, 
Chertsey, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
St. Peter's Hospital, Ashford & St. Peter's Hospitals NHS Foundation Trust, Surrey, 
Chertsey, ENG, GB 
OverviewLocationsClinical Research

Overview

Peter Reynolds practices in Chertsey, United Kingdom. Mr. Reynolds is highly rated in 4 conditions, according to our data. His top areas of expertise are Infant Respiratory Distress Syndrome, Premature Infant, Intraventricular Hemorrhage of the Newborn, and Bronchopulmonary Dysplasia.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St. Peter's Hospital, Ashford & St. Peter's Hospitals NHS Foundation Trust, Surrey, Chertsey, ENG, United Kingdom
Other Locations
Ashford And St Peter's Hospitals NHS Foundation Trust, Ashford, ENG, United Kingdom
Egham, ENG, United Kingdom
St. Peter's Hospital, Ashford And St. Peter's Hospitals NHSFT, Guildford Road, Surrey, Guildford, ENG KT160PZ, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drug: SHP607
Study Phase: Phase 2
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Enrollment Status: Terminated
Publish Date: March 24, 2023
Intervention Type: Other
Comparison of the IntellO2 - Precision Flow Automatic FiO2 Controller to Manual Control for Optimizing Oxygenation in Preterm Infants Receiving High Flow Nasal Cannula Therapy
Comparison of the IntellO2 - Precision Flow Automatic FiO2 Controller to Manual Control for Optimizing Oxygenation in Preterm Infants Receiving High Flow Nasal Cannula Therapy
Enrollment Status: Completed
Publish Date: June 27, 2018
Intervention Type: Device, Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

15 Total Publications

A novel human milk fortifier supports adequate growth in very low birth weight infants: a non-inferiority randomised controlled trial.
A novel human milk fortifier supports adequate growth in very low birth weight infants: a non-inferiority randomised controlled trial.
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: April 17, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reynolds's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile